Multiple Chemical Class‐Based Potent VEGFR2 Inhibitors as Anticancer Therapeutics: Structure–Activity Relationship and Chemicobiological Interactions Studies
Rinki Prasad Bhagat,
Ajeya Samanta,
Avik Maji,
Abhik Paul,
Sourav Mondal,
Abdul Qadir,
Nikki Gupta,
Balaram Ghosh,
Tapan Kumar Maity
Wiley ·
2026-11-17
· DOI 10.1002/cmdc.70579
The publisher did not provide an abstract — full text is available via the link below.
Rinki Prasad Bhagat, Ajeya Samanta, Avik Maji, Abhik Paul, Sourav Mondal, Abdul Qadir et al. Multiple Chemical Class‐Based Potent VEGFR2 Inhibitors as Anticancer Therapeutics: Structure–Activity Relationship and Chemicobiological Interactions Studies. // ChemMedChem. – 2026. – DOI: 10.1002/cmdc.70579. – URL: https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cmdc.70579?af=R
Rinki Prasad Bhagat, Ajeya Samanta, Avik Maji, Abhik Paul, Sourav Mondal, Abdul Qadir, Nikki Gupta, Balaram Ghosh, & Tapan Kumar Maity (2026). Multiple Chemical Class‐Based Potent VEGFR2 Inhibitors as Anticancer Therapeutics: Structure–Activity Relationship and Chemicobiological Interactions Studies. ChemMedChem. https://doi.org/10.1002/cmdc.70579
Rinki Prasad Bhagat, et al. “Multiple Chemical Class‐Based Potent VEGFR2 Inhibitors as Anticancer Therapeutics: Structure–Activity Relationship and Chemicobiological Interactions Studies.” ChemMedChem, 2026. doi:10.1002/cmdc.70579.
@article{Bhagat2026,
title = {Multiple Chemical Class‐Based Potent VEGFR2 Inhibitors as Anticancer Therapeutics: Structure–Activity Relationship and Chemicobiological Interactions Studies},
author = {Bhagat, Rinki Prasad and Samanta, Ajeya and Maji, Avik and Paul, Abhik and Mondal, Sourav and Qadir, Abdul and Gupta, Nikki and Ghosh, Balaram and Maity, Tapan Kumar},
journal = {ChemMedChem},
year = {2026},
doi = {10.1002/cmdc.70579},
url = {https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cmdc.70579?af=R}
}